Canton Strategic Holdings Inc (CNTN) vs ProQR Therapeutics N.V. (PRQR)
A side-by-side comparison of Canton Strategic Holdings Inc and ProQR Therapeutics N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTN
Canton Strategic Holdings Inc
$2.41HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
PRQR
ProQR Therapeutics N.V.
$1.65HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT
Total return — CNTN vs PRQR
growth of $100 · dividends reinvested · last 5yCNTN -99.8% (-71.8%/yr)PRQR -76.2% (-25.0%/yr)PRQR compounded faster over this window
Log scale — wide-divergence pair
CNTN PRQR
CNTN vs PRQR: by the numbers
- •CNTN is the larger company ($186M vs $173M market cap).
- •Both run net losses; PRQR's is the smaller (-229.20% vs -6559.27% net margin).
Metrics side by side
Valuation
| Metric | CNTN | PRQR |
|---|---|---|
| P/S ratio | 124.25 | 8.06 |
| P/B ratio | 0.41 | 1.91 |
Profitability
| Metric | CNTN | PRQR |
|---|---|---|
| Gross margin | 0.00% | 83.01% |
| Operating margin | 0.00% | -275.91% |
| Net margin | -6559.27% | -229.20% |
| ROE | -21.57% | -54.27% |
| ROIC | -9.57% | -42.61% |
Growth (annualized)
| Metric | CNTN | PRQR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 94.34% |
| Total return CAGR (5Y) | N/A | -26.23% |
Go deeper
Dig into the metrics
Canton Strategic ROEProQR Therapeutics ROECanton Strategic operating marginProQR Therapeutics operating marginCanton Strategic revenue growthProQR Therapeutics revenue growthCanton Strategic free cash flowProQR Therapeutics free cash flow
Canton Strategic & ProQR Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.